Zimmer Biomet Holdings Inc (ZBH)

Currency in USD
88.29
+0.23(+0.26%)
Closed·
88.290.00(0.00%)
·
Advertisement
ZBH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
87.1188.81
52 wk Range
79.12106.88
Key Statistics
Prev. Close
88.06
Open
88.13
Day's Range
87.11-88.81
52 wk Range
79.12-106.88
Volume
1.54M
Average Volume (3m)
2.15M
1-Year Change
-10.9711%
Book Value / Share
65.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZBH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
107.57
Upside
+21.84%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

9 Buy
18 Hold
0 Sell
Ratings:
27 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 107.57
(+21.84% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BMO Capital
Hold96.00+8.73%-Maintain28/09/2026
Canaccord
Hold100.00+13.26%83.00Maintain10/08/2026
Bernstein SocGen Group
Hold93.00+5.33%91.00Maintain06/08/2026
Baird
Hold104.00+17.79%92.00Maintain06/08/2026
BMO Capital
Hold96.00+8.73%95.00Maintain06/08/2026

Zimmer Biomet Holdings Inc SWOT Analysis


Strategic Crossroads
Zimmer Biomet navigates challenging market conditions while pursuing strategic acquisitions in robotic orthopedic surgery to secure long-term competitive advantages.
Financial Headwinds
Analyst price targets range from $101 to $125, reflecting mixed sentiment amid increased operational expenditures and tariff impacts expected to pressure profit margins.
Product Pipeline Promise
Delve into how two major knee product launches in 2025 could revitalize Zimmer's core business, potentially offsetting recent underperformance in the U.S. Knees segment.
Competitive Evolution
Explore Zimmer Biomet's positioning in the evolving orthopedic device market, where the Monogram Technologies acquisition signals commitment to leadership in robotic surgery technology.
Read full SWOT analysis

Zimmer Biomet Holdings Inc Earnings Call Summary for Q2/2026

  • Zimmer Biomet beat Q2 estimates with $2.07 EPS vs. $2.01 expected and $2.18B revenue vs. $2.14B forecast; shares rose 3.59% premarket.
  • Company raised 2026 guidance: organic revenue growth to 2.25%-3.25% from 1%-3%; adjusted EPS to $8.47-$8.59; share buybacks to $1B from $750M.
  • Hip sales grew 5.1%, technology/data segment surged 21.5%; U.S. organic growth of 4.6% outpaced 4%-5% market estimate amid salesforce overhaul.
  • CEO Tornos said U.S. salesforce transition progressing better than expected; expects 50+ new products over 36 months including ROSA Shoulder robotics.
  • Margins pressured by investments and 80-100 bps pricing erosion; knee sales weak internationally, down 1.5%; China remains drag on growth.
Last Updated: 05/08/2026, 14:44
Read Full Transcript

Earnings

Latest Release
05/08/2026
EPS / Forecast
2.07 / 2.01
Revenue / Forecast
2.18B / 2.14B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.12%
Dividend Yield
1.09%
Industry Median 1.44%
Annualised payout
0.96
Paid unevenly
5-Years Growth
-
Growth Streak

Compare ZBH to Peers and Sector

Metrics to compare
ZBH
Peers
Sector
Relationship
P/E Ratio
20.8x28.3x−0.4x
PEG Ratio
-−1.310.00
Price/Book
1.3x1.6x2.6x
Price / LTM Sales
2.0x1.8x3.0x
Upside (Analyst Target)
22.2%27.9%56.4%
Fair Value Upside
Unlock29.7%7.9%Unlock

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
128.31M67.27%11.40B
Other Institutional Investors
74.73M32.73%6.64B
Public Companies & Retail Investors
0.000.00%0.00
Total
203.05M100.00%18.04B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dodge & Cox12.65%24,124,7352,143,000
BlackRock, Inc.8.19%15,614,8471,387,067

People Also Watch

57.47
FTV
+2.92%
56.37
BALL
-0.23%
308.49
LH
+1.28%
76.07
IR
+1.09%
101.06
CCEP
+0.27%

FAQ

What Is the Zimmer Biomet (NYSE: ZBH) Share Price Today?

The Zimmer Biomet stock price today is 88.29 USD.

What Stock Exchange Does Zimmer Biomet (ZBH) Trade On?

Zimmer Biomet is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Zimmer Biomet?

The stock symbol (also called a 'ticker') for Zimmer Biomet is "ZBH."

Does Zimmer Biomet Pay Dividends? What’s The Current ZBH Dividend Yield?

Yes, ZBH Pays Dividends to its Shareholders. The current Zimmer Biomet dividend yield is 1.09%.

What Is the Current Zimmer Biomet Market Capitalisation?

As of today, Zimmer Biomet (NYSE: ZBH) market cap is 16.80B USD.

What Is Zimmer Biomet's (ZBH) Earnings Per Share (TTM)?

The Zimmer Biomet EPS is currently 4.12 (Trailing Twelve Months).

When Is the Next Zimmer Biomet Earnings Date?

Zimmer Biomet's next earnings report will be released on 04/11/2026.

Is ZBH a Buy or Sell From a Technical Analyst Perspective?

Based on today's Zimmer Biomet moving averages and other technical indicators, the daily buy/sell signal for ZBH stock is Strong Sell.

How Many Times Has Zimmer Biomet Stock Split?

Zimmer Biomet has split 0 times. (See the ZBH stock split history page for full effective split date and price information.)

How Many Employees Does Zimmer Biomet Have?

Zimmer Biomet has 17000 employees, based on their latest Companies House report.

What is the current trading status of Zimmer Biomet (NYSE: ZBH)?

As of 02/10/2026, Zimmer Biomet (ZBH) is trading at a share price of 88.29 USD, with a previous close of 88.06 USD. The stock has fluctuated within a day range of 87.11 USD to 88.81 USD, while its 52-week range spans from 79.12 USD to 106.88 USD.

What Is Zimmer Biomet (ZBH) Price Target According to Analysts?

The average 12-month price target for Zimmer Biomet is 107.57 USD, with a high estimate of 130 USD and a low estimate of 93 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +21.84% Upside potential.

What Is the ZBH Premarket Price?

ZBH's last pre-market stock price is 88.36 USD. The pre-market share volume is 302.00, and the stock has decreased by 0.30, or 0.34%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.